Strategic management of biotechnology agents

Area of Science:

• Pharmacoeconomics
• Health Services Management
• Biotechnology

Background:

• Pharmacists require strategic management skills to influence technology adoption in healthcare institutions.
• Biologic response modifiers (BRMs) present complex challenges and opportunities for pharmacy practice.
• Effective management of BRMs necessitates a value-driven approach.

Purpose of the Study:

• To describe a strategic management framework for pharmacists utilizing biologic response modifiers.
• To highlight the role of pharmacoeconomic analysis in managing biotechnology agents.
• To emphasize the need for pharmacists to lead in the integration of new biotechnologies.

Main Methods:

• Environmental scanning to assess institutional needs and market trends.
• Analysis of clinical and pharmacoeconomic data for BRMs like filgrastim and sargramostim.
• Development of clinical management strategies tailored to biotechnology agents.

Main Results:

• Strategic management enhances pharmacists' participation in technology decisions.
• Maximizing the fit between BRMs, institutions, and the healthcare environment is crucial.
• Pharmacoeconomic expertise and monitoring skills are vital for managing biotechnology agents.

Conclusions:

• Pharmacists are well-positioned to manage biotechnology agents through strategic and pharmacoeconomic approaches.
• Developing robust information databases for biotechnology agents is key to professional advancement.
• This strategic approach enables pharmacists to meet the challenges and capitalize on opportunities in biotechnology.